Migraine and digestive disorders;Migraine et troubles digestifs

Gastroenterologie Clinique et Biologique

Volumn 29, Issue 2, 2005, Pages 156-161

  Pradalier, André ^a   Devars Du Mayne, Jean François ^a,b  

^a HÔPITAL LOUIS MOURIER   (France)

^b AMERICAN HOSPITAL OF PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOTAMINE DERIVATIVE; GRANISETRON; ONDANSETRON; SEROTONIN 1 AGONIST; SEROTONIN 3 ANTAGONIST; SUMATRIPTAN;

CLINICAL FEATURE; DISEASE CLASSIFICATION; GASTROINTESTINAL DISEASE; HUMAN; MIGRAINE; MIGRAINE AURA; NAUSEA; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; REVIEW; VOMITING;

EID: 15044339453     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(05)80720-1     Document Type: Short Survey

References (38)

1. nd ed. Cephalalgia 2004;24(Suppl 1):24-150.
2. Caroli J. les ictères par rétention. Paris: Masson, 1956.
3. Laugier R. Allergie et douleurs abdominales: les équivalents digestifs de la migraine. Paris: Masson, 1983.
4. ANAES. Prise en charge diagnostique et thérapeutique de la migraine chez l'adulte et chez l'enfant. Rev Neurol 2003;159:4s7-118.
5. Pradalier A, Auray JP, El Hasnaoui A, Alzahouri K, Dartigues JF, Duru G, et al. Economic impact of migraine and other episodic headaches in France. Data from the GRIM 2000 study. Pharmacoeconomic 2004;22:985-99.
6. Saddier P, Michel P, Jacquier-Garcia M, Tison S, Vivares C, Milan J, et al. Migraines et céphalées en médecine géné rale. In: Henry P, Duru G, Chazot G, et al. La migraine en France. Montrouge: John libbey-eurotext, 1993.
7. Henry P, Duru G, Chazot G, Dartigues JF et le GRIM. La migraine en france. Montrouge France: John libbey-eurotext, 1993.
8. Henry P, Auray JP, Gaudin AF, Dartigues JF, Duru G, Lanteri-Minet M, et al. Prevalence and clinical characteristics of migraine in France. Neurology 2002;59:232-7.
9. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med 2002;346:257-70.
10. Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet 2001;357:1016-7.
11. Woods RP, Iacoboni M, Mazziotta JC. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331:1689-92.
12. Sanchez dR, Bakker D, Wu O, Agosti R, Mitsikostas DD, Ostergaard L, et al. Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia 1999;19:701-7.
13. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-7.
14. Edvinsson L. Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications. CNS Drugs 2001;15:745-53.
15. Pradalier A, Launay JM, Dry J, Dreux C. Rôle de la sérotonine plaquettaire dans la migraine commune: taux et captation. Presse Med 1983;12:2311-4.
16. Soliman H, Pradalier A, Launay JM, Dry J, Dreux C. Decreased phenol and tyramine sulphoconjugation by platelets in dietary migraine. In: Clifford-Rose ed. Advances in headache research. Londres: John Libbey 1987:117-23.
17. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 2000;60:1259-87.
18. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001;358:1668-75.
19. Jamieson DG. The safety of triptans in the treatment of patients with migraine. Am J Med 2002;112:135-40.
20. Rowat BM, Merrill CF, Davis A, South V. A double-blind comparison of granisetron and placebo for the treatment of acute migraine in the emergency department. Cephalalgia 1991;11:207-13.
21. Annequin D, Bousser MG, de Lignieres B, Fabre N, Massiou H, Pradalier A, et al. La migraine. Paris: Edition INSERM, 1998.
22. Pradalier A, Launay JM, Dry J, Dreux C, Artigou C. Migraine commune. Variation des catécholamines conjuguées et non conjuguées. Presse Med 1985;14:583-5.
23. Kaufman J, Levine I. Acute gastric dilatation of the stomach during attack of migraine. Radiology 1936;27:301-2.
24. Boyle R, Behan PO, Sutton JA. A correlation between severity of migraine and delayed gastric emptying measured by an epigastric impedance method. Br J Clin Pharmacol 1990;30:405-9.
25. Volans GN. The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol 1975;2:57-63.
26. Waelkens J. Domperidone in the prevention of complete classical migraine. Br Med J (Clin Res Ed) 1982;284:944.
27. Kemper RH, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia 2001;21:549-57.
28. Haimart M, Pradalier A, Launay JM, Dreux C, Dry J. Whole blood and plasma histamine in common migraine. Cephalalgia 1987;7:39-42.
29. Gasbarrini A, De Luca A, Fiore G, Gambrielli M, Franceschi F, Ojetti V, et al. Beneficial effects of Helicobacter pylori eradication on migraine. Hepatogastroenterology 1998;45:765-70.
30. Peatfield RC, Glover V, Littlewood JT, Sandier M, Clifford RF. The prevalence of diet-induced migraine. Cephalalgia 1984;3:231-234.
31. Pradalier A, de Saint MP, Lamy F, Launay JM. Immunocyte enumeration in duodenal biopsies of migraine without aura patients with or without food-induced migraine. Cephalalgia 1994;14:365-7.
32. Holtmann G, Kurth T, Neufang-Hueber J, Goebell H, Diener H, et al.: Association between migraine and symptoms of functionnal gastrointestinal disorders (abstract). Gastroenterology 1999;114:A188.
33. Bueno L, Fioramonti J. Troubles fonctionnels intestinaux: les traitements de demain. In: Dapoigny M, eds. Troubles fonctionnels digestifs. Paris: Elsevier, 1999:94-102.
34. Bueno L, Fioramonti J, Garcia-Villar R. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain. Am J Physiol Gastrointest Liver Physiol 2000;278:G670-6.
35. nd ed. MacLean VA: Degnon associates, 2000.
36. Coulie B, Tack J, Gevers A, Janssens J. Influence of sumatriptan induced colonic relaxation on the perception of colonic distention in man (abstract). Gastroenterology 1997;112:A715.
37. Grossi LG, Ciccaglione AF, Cappello G, Ferri A. Effect of the 5-HT1 agonist sumatriptan on oesophageal mobility in patients with unspecified motor abnormalities (abstract). Gastroenterology 2000;118:A3216.
38. Gabrielli M, Cremonini F, Fiore G, Addolorato G, Padalino C, Candelli M, et al. Association between migraine and Celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol 2003;98:625-9.